CTOs on the Move

DEM Biopharma, Inc.

www.dembiopharma.com

 
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Dont eat me (DEM) and ‘Eat me (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is supported by a syndicate of biotech investors and headquartered in Boston, MA.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Peter Mayer

Peter Mayer is a New Orleans, LA-based company in the Business Services sector.

HonorBridge

Interesse International

Interesse International is a El Segundo, CA-based company in the Business Services sector.

Welding Technologies

Welding Technologies is a Gainesville, GA-based company in the Business Services sector.

City of Oak Park

The City of Oak Park is a diverse and vibrant community that prides itself on being a family-oriented city. The City spans 5.5 square miles and is home to over 30,000 citizens. Oak Park has wonderful resources to draw from, including our 10 public pa...